Clear Cell Histology
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma (NCT05155033) | National Cancer Institute (NCI) | 2022-08-18 |
Track Clear Cell Histology automatically
Every clearance here is in the API, with alerts when new ones post.